Capital Advisors Ltd’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Sell |
4
-19
| -83% | -$4.75K | ﹤0.01% | 1227 |
|
|
2025
Q1 | $3K | Sell |
23
-30
| -57% | -$3.91K | ﹤0.01% | 992 |
|
|
2024
Q4 | $7K | Buy |
53
+29
| +121% | +$3.83K | ﹤0.01% | 875 |
|
|
2024
Q3 | $3K | Hold |
24
| – | – | ﹤0.01% | 1005 |
|
|
2024
Q2 | $3K | Hold |
24
| – | – | ﹤0.01% | 1001 |
|
|
2024
Q1 | $3K | Hold |
24
| – | – | ﹤0.01% | 984 |
|
|
2023
Q4 | $3K | Buy |
24
+1
| +4% | +$125 | ﹤0.01% | 950 |
|
|
2023
Q3 | $3K | Buy |
+23
| New | +$3K | ﹤0.01% | 943 |
|
|
2023
Q1 | – | Sell |
-51
| Closed | -$6K | – | 1429 |
|
|
2022
Q4 | $6K | Buy |
51
+3
| +6% | +$353 | ﹤0.01% | 631 |
|
|
2022
Q3 | $5K | Buy |
+48
| New | +$5K | ﹤0.01% | 642 |
|
|
2022
Q2 | – | Sell |
-7
| Closed | -$1K | – | 1207 |
|
|
2022
Q1 | $1K | Buy |
7
+5
| +250% | +$714 | ﹤0.01% | 754 |
|
|
2021
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 888 |
|